{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:59:20Z","timestamp":1790873960328,"version":"4.1.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100016387","name":"Grifols","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016387","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j intensive care"],"DOI":"10.1186\/s40560-025-00836-5","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:46:23Z","timestamp":1764269183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Management of endothelial dysfunction in septic shock: role of albumin administration"],"prefix":"10.1186","volume":"14","author":[{"given":"Ignacio","family":"Martin-Loeches","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Einav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Conway Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"1","key":"836_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/cvr\/cvaa070","volume":"117","author":"EV Dolmatova","year":"2021","unstructured":"Dolmatova EV, Wang K, Mandavilli R, Griendling KK. The effects of sepsis on endothelium and clinical implications. Cardiovasc Res. 2021;117(1):60\u201373. https:\/\/doi.org\/10.1093\/cvr\/cvaa070.","journal-title":"Cardiovasc Res"},{"issue":"11","key":"836_CR2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247. https:\/\/doi.org\/10.1007\/s00134-021-06506-y.","journal-title":"Intensive Care Med"},{"key":"836_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.828968","volume":"10","author":"J Fernandez-Sarmiento","year":"2022","unstructured":"Fernandez-Sarmiento J, Schlapbach LJ, Acevedo L, Santana CR, Acosta Y, Diana A, et al. Endothelial damage in sepsis: the importance of systems biology. Front Pediatr. 2022;10:828968. https:\/\/doi.org\/10.3389\/fped.2022.828968.","journal-title":"Front Pediatr"},{"issue":"2","key":"836_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/17512433.2018.1412827","volume":"11","author":"R Ferrer","year":"2018","unstructured":"Ferrer R, Mateu X, Maseda E, Yebenes JC, Aldecoa C, De Haro C, et al. Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients. Expert Rev Clin Pharmacol. 2018;11(2):125\u201337. https:\/\/doi.org\/10.1080\/17512433.2018.1412827.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"7577","key":"836_CR5","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1136\/bmj.38985.398704.7C","volume":"333","author":"S Finfer","year":"2006","unstructured":"Finfer S, Bellomo R, McEvoy S, Lo SK, Myburgh J, Neal B, et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ. 2006;333(7577):1044. https:\/\/doi.org\/10.1136\/bmj.38985.398704.7C.","journal-title":"BMJ"},{"issue":"3","key":"836_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/01.Sla.0000055547.93484.87","volume":"237","author":"JL Vincent","year":"2003","unstructured":"Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237(3):319\u201334. https:\/\/doi.org\/10.1097\/01.Sla.0000055547.93484.87.","journal-title":"Ann Surg"},{"issue":"5","key":"836_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.medin.2017.03.004","volume":"41","author":"A Hern\u00e1ndez-Tejedor","year":"2017","unstructured":"Hern\u00e1ndez-Tejedor A, Pe\u00f1uelas O, Sirgo Rodr\u00edguez G, Llompart-Pou JA, Palencia Herrej\u00f3n E, Estella A, et al. Recommendations of the working groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients. Med Intensiva. 2017;41(5):285\u2013305. https:\/\/doi.org\/10.1016\/j.medin.2017.03.004.","journal-title":"Med Intensiva"},{"issue":"4","key":"836_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/cc13991","volume":"18","author":"JL Vincent","year":"2014","unstructured":"Vincent JL, Russell JA, Jacob M, Martin G, Guidet B, Wernerman J, et al. Albumin administration in the acutely ill: what is new and where next? Crit Care. 2014;18(4):231. https:\/\/doi.org\/10.1186\/cc13991.","journal-title":"Crit Care"},{"issue":"6","key":"836_CR9","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest. 1992;101(6):1644\u201355. https:\/\/doi.org\/10.1378\/chest.101.6.1644.","journal-title":"Chest"},{"issue":"4","key":"836_CR10","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/01.Ccm.0000050454.01978.3b","volume":"31","author":"MM Levy","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference. Crit Care Med. 2003;31(4):1250\u20136. https:\/\/doi.org\/10.1097\/01.Ccm.0000050454.01978.3b.","journal-title":"Crit Care Med"},{"issue":"8","key":"836_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"issue":"10219","key":"836_CR12","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease study. Lancet. 2020;395(10219):200\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7.","journal-title":"Lancet"},{"issue":"3","key":"836_CR13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s00134-008-1363-6","volume":"35","author":"A Rodriguez","year":"2009","unstructured":"Rodriguez A, Lisboa T, Blot S, Martin-Loeches I, Sol\u00e9-Violan J, De Mendoza D, et al. Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough. Intensive Care Med. 2009;35(3):430\u20138. https:\/\/doi.org\/10.1007\/s00134-008-1363-6.","journal-title":"Intensive Care Med"},{"issue":"20","key":"836_CR14","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, Chang CH, Elliott CF, Xu Z, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321(20):2003\u201317. https:\/\/doi.org\/10.1001\/jama.2019.5791.","journal-title":"JAMA"},{"issue":"2","key":"836_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1164\/rccm.202311-2086SO","volume":"210","author":"AC Gordon","year":"2024","unstructured":"Gordon AC, Alipanah-Lechner N, Bos LD, Dianti J, Diaz JV, Finfer S, et al. From ICU syndromes to ICU subphenotypes: consensus report and recommendations for developing precision medicine in the ICU. Am J Respir Crit Care Med. 2024;210(2):155\u201366. https:\/\/doi.org\/10.1164\/rccm.202311-2086SO.","journal-title":"Am J Respir Crit Care Med"},{"issue":"23","key":"836_CR16","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376(23):2235\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1703058.","journal-title":"N Engl J Med"},{"issue":"1","key":"836_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s42003-023-04897-w","volume":"6","author":"SA Groten","year":"2023","unstructured":"Groten SA, Smit ER, Janssen EFJ, van den Eshof BL, van Alphen FPJ, van der Zwaan C, et al. Multi-omics delineation of cytokine-induced endothelial inflammatory states. Communications Biology. 2023;6(1):525. https:\/\/doi.org\/10.1038\/s42003-023-04897-w.","journal-title":"Communications Biology"},{"key":"836_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-3-319-96445-4_3","volume":"1097","author":"HH Lipowsky","year":"2018","unstructured":"Lipowsky HH. Role of the glycocalyx as a barrier to leukocyte-endothelium adhesion. Adv Exp Med Biol. 2018;1097:51\u201368. https:\/\/doi.org\/10.1007\/978-3-319-96445-4_3.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"836_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc13733","volume":"18","author":"R Zonneveld","year":"2014","unstructured":"Zonneveld R, Martinelli R, Shapiro NI, Kuijpers TW, Pl\u00f6tz FB, Carman CV. Soluble adhesion molecules as markers for sepsis and the potential pathophysiological discrepancy in neonates, children and adults. Crit Care. 2014;18(1):204. https:\/\/doi.org\/10.1186\/cc13733.","journal-title":"Crit Care"},{"key":"836_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cyto.2016.08.028","volume":"88","author":"B Amalakuhan","year":"2016","unstructured":"Amalakuhan B, Habib SA, Mangat M, Reyes LF, Rodriguez AH, Hinojosa CA, et al. Endothelial adhesion molecules and multiple organ failure in patients with severe sepsis. Cytokine. 2016;88:267\u201373. https:\/\/doi.org\/10.1016\/j.cyto.2016.08.028.","journal-title":"Cytokine"},{"key":"836_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117180","volume":"178","author":"F Tang","year":"2024","unstructured":"Tang F, Zhao X-L, Xu L-Y, Zhang J-N, Ao H, Peng C. Endothelial dysfunction: pathophysiology and therapeutic targets for sepsis-induced multiple organ dysfunction syndrome. Biomed Pharmacother. 2024;178:117180. https:\/\/doi.org\/10.1016\/j.biopha.2024.117180.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"836_CR22","doi-asserted-by":"publisher","first-page":"L1107","DOI":"10.1152\/ajplung.2000.278.6.L1107","volume":"278","author":"T Ferro","year":"2000","unstructured":"Ferro T, Neumann P, Gertzberg N, Clements R, Johnson A. Protein kinase C-alpha mediates endothelial barrier dysfunction induced by TNF-alpha. Am J Physiol Lung Cell Mol Physiol. 2000;278(6):L1107\u201317. https:\/\/doi.org\/10.1152\/ajplung.2000.278.6.L1107.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1\u20132","key":"836_CR23","doi-asserted-by":"publisher","DOI":"10.4161\/21688370.2014.974448","volume":"3","author":"A K\u00e1sa","year":"2015","unstructured":"K\u00e1sa A, Csortos C, Verin AD. Cytoskeletal mechanisms regulating vascular endothelial barrier function in response to acute lung injury. Tissue Barriers. 2015;3(1\u20132):e974448. https:\/\/doi.org\/10.4161\/21688370.2014.974448.","journal-title":"Tissue Barriers"},{"issue":"1","key":"836_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/MCC.0b013e3282f269b9","volume":"14","author":"NA Maniatis","year":"2008","unstructured":"Maniatis NA, Orfanos SE. The endothelium in acute lung injury\/acute respiratory distress syndrome. Curr Opin Crit Care. 2008;14(1):22\u201330. https:\/\/doi.org\/10.1097\/MCC.0b013e3282f269b9.","journal-title":"Curr Opin Crit Care"},{"key":"836_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev.bioeng.9.060906.151959","volume":"9","author":"S Weinbaum","year":"2007","unstructured":"Weinbaum S, Tarbell JM, Damiano ER. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng. 2007;9:121\u201367. https:\/\/doi.org\/10.1146\/annurev.bioeng.9.060906.151959.","journal-title":"Annu Rev Biomed Eng"},{"issue":"2","key":"836_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/ACO.0b013e328328d1b6","volume":"22","author":"D Chappell","year":"2009","unstructured":"Chappell D, Westphal M, Jacob M. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Curr Opin Anaesthesiol. 2009;22(2):155\u201362. https:\/\/doi.org\/10.1097\/ACO.0b013e328328d1b6.","journal-title":"Curr Opin Anaesthesiol"},{"issue":"1","key":"836_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13054-022-04154-2","volume":"26","author":"RO Dull","year":"2022","unstructured":"Dull RO, Hahn RG. The glycocalyx as a permeability barrier: basic science and clinical evidence. Crit Care. 2022;26(1):273. https:\/\/doi.org\/10.1186\/s13054-022-04154-2.","journal-title":"Crit Care"},{"issue":"10","key":"836_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224563","volume":"14","author":"N van Mourik","year":"2019","unstructured":"van Mourik N, Metske HA, Hofstra JJ, Binnekade JM, Geerts BF, Schultz MJ, et al. Cumulative fluid balance predicts mortality and increases time on mechanical ventilation in ARDS patients: an observational cohort study. PLoS ONE. 2019;14(10):e0224563. https:\/\/doi.org\/10.1371\/journal.pone.0224563.","journal-title":"PLoS ONE"},{"key":"836_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1203827","volume":"10","author":"R Cusack","year":"2023","unstructured":"Cusack R, Bos LD, Povoa P, Martin-Loeches I. Endothelial dysfunction triggers acute respiratory distress syndrome in patients with sepsis: a narrative review. Front Med. 2023;10:1203827. https:\/\/doi.org\/10.3389\/fmed.2023.1203827.","journal-title":"Front Med"},{"issue":"3","key":"836_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11901-020-00521-1","volume":"19","author":"M Tufoni","year":"2020","unstructured":"Tufoni M, Baldassarre M, Zaccherini G, Antognoli A, Caraceni P. Hemodynamic and systemic effects of albumin in patients with advanced liver disease. Curr Hepatol Rep. 2020;19(3):147\u201358. https:\/\/doi.org\/10.1007\/s11901-020-00521-1.","journal-title":"Curr Hepatol Rep"},{"issue":"1","key":"836_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13613-020-00697-1","volume":"10","author":"C Aldecoa","year":"2020","unstructured":"Aldecoa C, Llau JV, Nuvials X, Artigas A. Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review. Ann Intensive Care. 2020;10(1):85. https:\/\/doi.org\/10.1186\/s13613-020-00697-1.","journal-title":"Ann Intensive Care"},{"issue":"7","key":"836_CR32","doi-asserted-by":"publisher","first-page":"H1011","DOI":"10.1152\/ajpheart.00829.2013","volume":"306","author":"RH Adamson","year":"2014","unstructured":"Adamson RH, Clark JF, Radeva M, Kheirolomoom A, Ferrara KW, Curry FE. Albumin modulates S1P delivery from red blood cells in perfused microvessels: mechanism of the protein effect. American J Physiol-Heart Circ Physiol. 2014;306(7):H1011\u20137. https:\/\/doi.org\/10.1152\/ajpheart.00829.2013.","journal-title":"American J Physiol-Heart Circ Physiol"},{"issue":"4","key":"836_CR33","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s10439-011-0429-8","volume":"40","author":"FE Curry","year":"2012","unstructured":"Curry FE, Adamson RH. Endothelial glycocalyx: permeability barrier and mechanosensor. Ann Biomed Eng. 2012;40(4):828\u201339. https:\/\/doi.org\/10.1007\/s10439-011-0429-8.","journal-title":"Ann Biomed Eng"},{"issue":"1","key":"836_CR34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1146\/annurev-bioeng-071813-104908","volume":"16","author":"JM Tarbell","year":"2014","unstructured":"Tarbell JM, Simon SI, Curry F-RE. Mechanosensing at the vascular interface. Annu Rev Biomed Eng. 2014;16(1):505\u201332. https:\/\/doi.org\/10.1146\/annurev-bioeng-071813-104908.","journal-title":"Annu Rev Biomed Eng"},{"issue":"Suppl 5","key":"836_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2036.16.s5.2.x","volume":"16","author":"TW Evans","year":"2002","unstructured":"Evans TW. Review article: albumin as a drug\u2013biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther. 2002;16(Suppl 5):6\u201311. https:\/\/doi.org\/10.1046\/j.1365-2036.16.s5.2.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"836_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2110-5820-3-4","volume":"3","author":"M Taverna","year":"2013","unstructured":"Taverna M, Marie A-L, Mira J-P, Guidet B. Specific antioxidant properties of human serum albumin. Ann Intensive Care. 2013;3(1):4. https:\/\/doi.org\/10.1186\/2110-5820-3-4.","journal-title":"Ann Intensive Care"},{"issue":"3","key":"836_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151005","volume":"11","author":"E Damiani","year":"2016","unstructured":"Damiani E, Ince C, Orlando F, Pierpaoli E, Cirioni O, Giacometti A, et al. Effects of the infusion of 4% or 20% human serum albumin on the skeletal muscle microcirculation in endotoxemic rats. PLoS ONE. 2016;11(3):e0151005. https:\/\/doi.org\/10.1371\/journal.pone.0151005.","journal-title":"PLoS ONE"},{"issue":"6","key":"836_CR38","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1097\/CCM.0b013e318211ff6e","volume":"39","author":"H Kremer","year":"2011","unstructured":"Kremer H, Baron-Menguy C, Tesse A, Gallois Y, Mercat A, Henrion D, et al. Human serum albumin improves endothelial dysfunction and survival during experimental endotoxemia: concentration-dependent properties*. Crit Care Med. 2011;39(6):1414\u201322. https:\/\/doi.org\/10.1097\/CCM.0b013e318211ff6e.","journal-title":"Crit Care Med"},{"issue":"1","key":"836_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13054-017-1745-7","volume":"21","author":"LN Torres","year":"2017","unstructured":"Torres LN, Chung KK, Salgado CL, Dubick MA, Torres Filho IP. Low-volume resuscitation with normal saline is associated with microvascular endothelial dysfunction after hemorrhage in rats, compared to colloids and balanced crystalloids. Crit Care. 2017;21(1):160. https:\/\/doi.org\/10.1186\/s13054-017-1745-7.","journal-title":"Crit Care"},{"issue":"4","key":"836_CR40","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1161\/hs0402.105555","volume":"33","author":"L Belayev","year":"2002","unstructured":"Belayev L, Pinard E, Nallet H, Seylaz J, Liu Y, Riyamongkol P, et al. Albumin therapy of transient focal cerebral ischemia. Stroke. 2002;33(4):1077\u201384. https:\/\/doi.org\/10.1161\/hs0402.105555.","journal-title":"Stroke"},{"issue":"6","key":"836_CR41","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1097\/00000542-200606000-00018","volume":"104","author":"M Jacob","year":"2006","unstructured":"Jacob M, Bruegger D, Rehm M, Welsch U, Conzen P, Becker BF. Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology. 2006;104(6):1223\u201331. https:\/\/doi.org\/10.1097\/00000542-200606000-00018.","journal-title":"Anesthesiology"},{"issue":"15","key":"836_CR42","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","volume":"370","author":"P Caironi","year":"2014","unstructured":"Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370(15):1412\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1305727.","journal-title":"N Engl J Med"},{"key":"836_CR43","first-page":"S115","volume":"37","author":"J Charpentier","year":"2011","unstructured":"Charpentier J, Mira JP. Efficacy and tolerance of hyperoncotic albumin administration in septic shock patients: the EARSS study. Intensive Care Med. 2011;37:S115.","journal-title":"Intensive Care Med"},{"issue":"10","key":"836_CR44","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1097\/01.Ccm.0000239119.57544.0c","volume":"34","author":"MJ Dubois","year":"2006","unstructured":"Dubois MJ, Orellana-Jimenez C, Melot C, De Backer D, Berre J, Leeman M, et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med. 2006;34(10):2536\u201340. https:\/\/doi.org\/10.1097\/01.Ccm.0000239119.57544.0c.","journal-title":"Crit Care Med"},{"issue":"6","key":"836_CR45","doi-asserted-by":"publisher","first-page":"R277","DOI":"10.1186\/cc10559","volume":"15","author":"C Adembri","year":"2011","unstructured":"Adembri C, Sgambati E, Vitali L, Selmi V, Margheri M, Tani A, et al. Sepsis induces albuminuria and alterations in the glomerular filtration barrier: a morphofunctional study in the rat. Crit Care. 2011;15(6):R277. https:\/\/doi.org\/10.1186\/cc10559.","journal-title":"Crit Care"},{"issue":"3","key":"836_CR46","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.mvr.2011.08.008","volume":"82","author":"P Bansch","year":"2011","unstructured":"Bansch P, Nelson A, Ohlsson T, Bentzer P. Effect of charge on microvascular permeability in early experimental sepsis in the rat. Microvasc Res. 2011;82(3):339\u201345. https:\/\/doi.org\/10.1016\/j.mvr.2011.08.008.","journal-title":"Microvasc Res"},{"issue":"4","key":"836_CR47","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.mehy.2012.12.039","volume":"80","author":"R Kumar","year":"2013","unstructured":"Kumar R, Kumar S, Lata S. Albumin infusion may deleteriously promote extracellular fluid overload without improving circulating hypovolemia in patients of advanced cirrhosis with diabetes mellitus and sepsis. Med Hypotheses. 2013;80(4):452\u20135. https:\/\/doi.org\/10.1016\/j.mehy.2012.12.039.","journal-title":"Med Hypotheses"},{"issue":"1","key":"836_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1846-3","volume":"22","author":"A Margraf","year":"2018","unstructured":"Margraf A, Herter JM, K\u00fchne K, Stadtmann A, Ermert T, Wenk M, et al. 6% hydroxyethyl starch (HES 130\/0.4) diminishes glycocalyx degradation and decreases vascular permeability during systemic and pulmonary inflammation in mice. Crit Care. 2018;22(1):111. https:\/\/doi.org\/10.1186\/s13054-017-1846-3.","journal-title":"Crit Care"},{"key":"836_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/clinpract15070120","author":"G Turcato","year":"2025","unstructured":"Turcato G, Zaboli A, Filippi L, Cipriano A, Ferretto P, Maggi M, et al. Endothelial damage in sepsis: the interplay of coagulopathy, capillary leak, and vasoplegia-a physiopathological study. Clin Pract. 2025. https:\/\/doi.org\/10.3390\/clinpract15070120.","journal-title":"Clin Pract"},{"issue":"4","key":"836_CR50","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/01.shk.0000209527.35743.b0","volume":"25","author":"LT van Eijk","year":"2006","unstructured":"van Eijk LT, Nooteboom A, Hendriks T, Sprong T, Netea MG, Smits P, et al. Plasma obtained during human endotoxemia increases endothelial albumin permeability in vitro. Shock. 2006;25(4):358\u201362. https:\/\/doi.org\/10.1097\/01.shk.0000209527.35743.b0.","journal-title":"Shock"},{"issue":"1","key":"836_CR51","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3892\/mmr.2015.4536","volume":"13","author":"YJ Zheng","year":"2016","unstructured":"Zheng YJ, Xu WP, Ding G, Gao YH, Wang HR, Pan SM. Expression of HMGB1 in septic serum induces vascular endothelial hyperpermeability. Mol Med Rep. 2016;13(1):513\u201321. https:\/\/doi.org\/10.3892\/mmr.2015.4536.","journal-title":"Mol Med Rep"},{"issue":"1","key":"836_CR52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/CCM.0b013e3181feb46a","volume":"39","author":"J Aman","year":"2011","unstructured":"Aman J, van der Heijden M, van Lingen A, Girbes AR, van Nieuw Amerongen GP, van Hinsbergh VW, et al. Plasma protein levels are markers of pulmonary vascular permeability and degree of lung injury in critically ill patients with or at risk for acute lung injury\/acute respiratory distress syndrome. Crit Care Med. 2011;39(1):89\u201397. https:\/\/doi.org\/10.1097\/CCM.0b013e3181feb46a.","journal-title":"Crit Care Med"},{"issue":"1","key":"836_CR53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1399-6576.2004.00270.x","volume":"48","author":"M Matejovic","year":"2004","unstructured":"Matejovic M, Krouzecky A, Rokyta R Jr, Novak I. Fluid challenge in patients at risk for fluid loading-induced pulmonary edema. Acta Anaesthesiol Scand. 2004;48(1):69\u201373. https:\/\/doi.org\/10.1111\/j.1399-6576.2004.00270.x.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"6","key":"836_CR54","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/aas.12130","volume":"57","author":"C Lundblad","year":"2013","unstructured":"Lundblad C, Axelberg H, Gr\u00e4nde PO. Treatment with the sphingosine-1-phosphate analogue FTY 720 reduces loss of plasma volume during experimental sepsis in the rat. Acta Anaesthesiol Scand. 2013;57(6):713\u20138. https:\/\/doi.org\/10.1111\/aas.12130.","journal-title":"Acta Anaesthesiol Scand"},{"key":"836_CR55","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-3-031-42205-8_10","volume-title":"Rational use of intravenous Fluids in critically Ill patients","author":"P Nasa","year":"2024","unstructured":"Nasa P, Kumar R, Juneja D, Gosh S. The Case for Albumin as Volume Expander and beyond. In: Malbrain MLNG, Wong A, Nasa P, Ghosh S, editors. Rational use of intravenous Fluids in critically Ill patients. Cham: Springer International Publishing; 2024. p. 227\u201342."},{"issue":"3","key":"836_CR56","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/17511437241259437","volume":"25","author":"J Bannard-Smith","year":"2024","unstructured":"Bannard-Smith J, Elrakhawy M, Norman G, Owen R, Felton T, Dark P. The efficacy, safety and effectiveness of hyperoncotic albumin solutions in patients with sepsis: a systematic review and meta-analysis. J Intensive Care Soc. 2024;25(3):308\u201318. https:\/\/doi.org\/10.1177\/17511437241259437.","journal-title":"J Intensive Care Soc"},{"issue":"1","key":"836_CR57","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00134-010-2039-6","volume":"37","author":"S Finfer","year":"2011","unstructured":"Finfer S, McEvoy S, Bellomo R, McArthur C, Myburgh J, Norton R. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med. 2011;37(1):86\u201396. https:\/\/doi.org\/10.1007\/s00134-010-2039-6.","journal-title":"Intensive Care Med"},{"key":"836_CR58","unstructured":"Randomised comparison of fluid resuscitation with human albumin solution or normal saline among critically ill patients (SAFE study): ISRCTN registry. Accessed Mar 2025. https:\/\/www.isrctn.com\/ISRCTN76588266"},{"key":"836_CR59","unstructured":"Early Albumin Resuscitation During Septic Shock (EARSS study): ClinicalTrials.gov. Accessed Mar 2025. https:\/\/clinicaltrials.gov\/study\/NCT00327704"},{"key":"836_CR60","unstructured":"Volume Replacement With Albumin in Severe Sepsis (ALBIOS): ClinicalTrials.gov. Accessed Mar 2025. https:\/\/clinicaltrials.gov\/study\/NCT00707122?tab=table"},{"issue":"9","key":"836_CR61","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1056\/NEJMoa067514","volume":"357","author":"J Myburgh","year":"2007","unstructured":"Myburgh J, Cooper DJ, Finfer S, Bellomo R, Norton R, Bishop N, et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med. 2007;357(9):874\u201384. https:\/\/doi.org\/10.1056\/NEJMoa067514.","journal-title":"N Engl J Med"},{"issue":"1","key":"836_CR62","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40560-025-00813-y","volume":"13","author":"J-L Vincent","year":"2025","unstructured":"Vincent J-L, Ferrer R, Taccone FS, Wiedermann CJ, Reinstrup P. Re-evaluating albumin use in traumatic brain injury. J Intensive Care. 2025;13(1):43. https:\/\/doi.org\/10.1186\/s40560-025-00813-y.","journal-title":"J Intensive Care"},{"issue":"2","key":"836_CR63","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/CCM.0b013e3181ffe217","volume":"39","author":"AP Delaney","year":"2011","unstructured":"Delaney AP, Dan A, McCaffrey J, Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med. 2011;39(2):386\u201391. https:\/\/doi.org\/10.1097\/CCM.0b013e3181ffe217.","journal-title":"Crit Care Med"},{"key":"836_CR64","doi-asserted-by":"publisher","unstructured":"Retraction note: Volume therapy in the critically ill: is there a difference? Intensive Care Med. 2014. 40 1 145 https:\/\/doi.org\/10.1007\/s00134-013-3164-9","DOI":"10.1007\/s00134-013-3164-9"},{"key":"836_CR65","doi-asserted-by":"publisher","unstructured":"Notice of formal retraction of an article by Dr Joachim Boldt. Br J Anaesth. 2014. 112 2 397 https:\/\/doi.org\/10.1093\/bja\/aet488","DOI":"10.1093\/bja\/aet488"},{"key":"836_CR66","doi-asserted-by":"publisher","unstructured":"Influence of Different Volume Therapies and Pentoxifylline Infusion on Circulating Soluble Adhesion Molecules in Critically Ill Patients: Retraction. Crit Care Med. 2023. 51 9 e198 https:\/\/doi.org\/10.1097\/ccm.0000000000005910","DOI":"10.1097\/ccm.0000000000005910"},{"issue":"3","key":"836_CR67","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bja.2020.07.034","volume":"125","author":"J Boldt","year":"2020","unstructured":"Boldt J, Heesen M, Welters I, Padberg W, Martin K, Hempelmann G. Retraction notice to \u201cDoes the type of volume therapy influence endothelial-related coagulation in the critically ill?\u201d [Br J Anaesth 75 (1995) 740\u20136]. Br J Anaesth. 2020;125(3):415. https:\/\/doi.org\/10.1016\/j.bja.2020.07.034.","journal-title":"Br J Anaesth"},{"issue":"6","key":"836_CR68","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00134-023-07056-1","volume":"49","author":"J Boldt","year":"2023","unstructured":"Boldt J, M\u00fcller M, Heesen M, Heyn O, Hempelmann G. Retraction note: Influence of different volume therapies on platelet function in the critically ill. Intensive Care Med. 2023;49(6):725. https:\/\/doi.org\/10.1007\/s00134-023-07056-1.","journal-title":"Intensive Care Med"},{"issue":"5","key":"836_CR69","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1213\/ane.0000000000000417","volume":"119","author":"SL Shafer","year":"2014","unstructured":"Shafer SL. Editor\u2019s note: notice of retraction. Anesth Analg. 2014;119(5):1225. https:\/\/doi.org\/10.1213\/ane.0000000000000417.","journal-title":"Anesth Analg"},{"issue":"22","key":"836_CR70","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa040232","volume":"350","author":"S Finfer","year":"2004","unstructured":"Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247\u201356. https:\/\/doi.org\/10.1056\/NEJMoa040232.","journal-title":"N Engl J Med"},{"issue":"6","key":"836_CR71","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1186\/s13054-014-0702-y","volume":"18","author":"JY Xu","year":"2014","unstructured":"Xu JY, Chen QH, Xie JF, Pan C, Liu SQ, Huang LW, et al. Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials. Crit Care. 2014;18(6):702. https:\/\/doi.org\/10.1186\/s13054-014-0702-y.","journal-title":"Crit Care"},{"key":"836_CR72","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4561","volume":"349","author":"A Patel","year":"2014","unstructured":"Patel A, Laffan MA, Waheed U, Brett SJ. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ. 2014;349:g4561. https:\/\/doi.org\/10.1136\/bmj.g4561.","journal-title":"BMJ"},{"issue":"1","key":"836_CR73","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1056\/NEJMc1405675","volume":"371","author":"CJ Wiedermann","year":"2014","unstructured":"Wiedermann CJ, Joannidis M. Albumin replacement in severe sepsis or septic shock. N Engl J Med. 2014;371(1):83. https:\/\/doi.org\/10.1056\/NEJMc1405675.","journal-title":"N Engl J Med"},{"issue":"11","key":"836_CR74","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00134-018-5253-2","volume":"44","author":"J Martensson","year":"2018","unstructured":"Martensson J, Bihari S, Bannard-Smith J, Glassford NJ, Lloyd-Donald P, Cioccari L, et al. Small volume resuscitation with 20% albumin in intensive care: physiological effects\u202f: the SWIPE randomised clinical trial. Intensive Care Med. 2018;44(11):1797\u2013806. https:\/\/doi.org\/10.1007\/s00134-018-5253-2.","journal-title":"Intensive Care Med"},{"key":"836_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.982969","volume":"9","author":"Z Ye","year":"2022","unstructured":"Ye Z, Gao M, Ge C, Lin W, Zhang L, Zou Y, et al. Association between albumin infusion and septic patients with coronary heart disease: a retrospective study based on medical information mart for intensive care III database. Front Cardiovasc Med. 2022;9:982969. https:\/\/doi.org\/10.3389\/fcvm.2022.982969.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"836_CR76","doi-asserted-by":"publisher","first-page":"18262","DOI":"10.1038\/s41598-025-03141-1","volume":"15","author":"Y Kang","year":"2025","unstructured":"Kang Y, Ahn SY, Kang MW. Exploring treatment effects and fluid resuscitation strategies in septic shock: a deep learning-based causal inference approach. Sci Rep. 2025;15(1):18262. https:\/\/doi.org\/10.1038\/s41598-025-03141-1.","journal-title":"Sci Rep"},{"key":"836_CR77","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jcrc.2016.04.019","volume":"35","author":"JL Vincent","year":"2016","unstructured":"Vincent JL, De Backer D, Wiedermann CJ. Fluid management in sepsis: the potential beneficial effects of albumin. J Crit Care. 2016;35:161\u20137. https:\/\/doi.org\/10.1016\/j.jcrc.2016.04.019.","journal-title":"J Crit Care"},{"issue":"12","key":"836_CR78","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1177\/10600280241236507","volume":"58","author":"JP Counts","year":"2024","unstructured":"Counts JP, Arnold J, Atyia S, Ogake S, Smith RM, Doepker B. The effect of albumin replacement on vasopressor duration in septic shock in patients with hypoalbuminemia. Ann Pharmacother. 2024;58(12):1179\u201386. https:\/\/doi.org\/10.1177\/10600280241236507.","journal-title":"Ann Pharmacother"},{"key":"836_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2025.155039","volume":"87","author":"RAF Cusack","year":"2025","unstructured":"Cusack RAF, Rodr\u00edguez A, Cantan B, Garduno A, Connolly E, Zilahi G, et al. Microcirculation properties of 20 % albumin in sepsis; a randomised controlled trial. J Crit Care. 2025;87:155039. https:\/\/doi.org\/10.1016\/j.jcrc.2025.155039.","journal-title":"J Crit Care"},{"issue":"1","key":"836_CR80","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13054-024-04827-0","volume":"28","author":"P Gabarre","year":"2024","unstructured":"Gabarre P, Desnos C, Morin A, Missri L, Urbina T, Bonny V, et al. Albumin versus saline infusion for sepsis-related peripheral tissue hypoperfusion: a proof-of-concept prospective study. Crit Care. 2024;28(1):43. https:\/\/doi.org\/10.1186\/s13054-024-04827-0.","journal-title":"Crit Care"},{"issue":"8","key":"836_CR81","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/08850666231170778","volume":"38","author":"L Geng","year":"2023","unstructured":"Geng L, Tian X, Gao Z, Mao A, Feng L, He C. Different concentrations of albumin versus crystalloid in patients with sepsis and septic shock: a meta-analysis of randomized clinical trials. J Intensive Care Med. 2023;38(8):679\u201389. https:\/\/doi.org\/10.1177\/08850666231170778.","journal-title":"J Intensive Care Med"},{"issue":"1","key":"836_CR82","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1574887108666131213120816","volume":"9","author":"A Farrugia","year":"2014","unstructured":"Farrugia A, Bansal M, Balboni S, Kimber MC, Martin GS, Cassar J. Choice of fluids in severe septic patients - a cost-effectiveness analysis informed by recent clinical trials. Rev Recent Clin Trials. 2014;9(1):21\u201330. https:\/\/doi.org\/10.2174\/1574887108666131213120816.","journal-title":"Rev Recent Clin Trials"},{"issue":"6","key":"836_CR83","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/aas.13559","volume":"64","author":"B Guidet","year":"2020","unstructured":"Guidet B, Ghout I, Ropers J, Aegerter P. Economic model of albumin infusion in septic shock: the EMAISS study. Acta Anaesthesiol Scand. 2020;64(6):781\u20138. https:\/\/doi.org\/10.1111\/aas.13559.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"3","key":"836_CR84","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jcrc.2006.11.005","volume":"22","author":"B Guidet","year":"2007","unstructured":"Guidet B, Mosqueda GJ, Priol G, Aegerter P. The COASST study: cost-effectiveness of albumin in severe sepsis and septic shock. J Crit Care. 2007;22(3):197\u2013203. https:\/\/doi.org\/10.1016\/j.jcrc.2006.11.005.","journal-title":"J Crit Care"},{"issue":"1","key":"836_CR85","doi-asserted-by":"publisher","first-page":"869","DOI":"10.4314\/ejhs.v29i1.8","volume":"29","author":"B Tigabu","year":"2019","unstructured":"Tigabu B, Davari M, Kebriaeezadeh A, Mojtahedzadeh M, Sadeghi K, Jahangard-Rafsanjani Z. Is albumin-based resuscitation in severe sepsis and septic shock justifiable? An evidence from a cost-effectiveness evaluation. Ethiop J Health Sci. 2019;29(1):869\u201376. https:\/\/doi.org\/10.4314\/ejhs.v29i1.8.","journal-title":"Ethiop J Health Sci"},{"key":"836_CR86","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2025-103244","author":"K Bennett","year":"2025","unstructured":"Bennett K, Viayna E, Stacey D, Southern D, Cramp ME. Hospital resource utilisation in patients with cirrhosis related ascites requiring paracentesis in England. Frontline Gastroenterol. 2025. https:\/\/doi.org\/10.1136\/flgastro-2025-103244.","journal-title":"Frontline Gastroenterol"},{"issue":"5","key":"836_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2025.107154","volume":"165","author":"J Fern\u00e1ndez","year":"2025","unstructured":"Fern\u00e1ndez J, Coll-Ortega C, Fuster C, Davis A, Sim\u00f3 P, Aceituno S, et al. Economic cost of long-term albumin treatment in cirrhotic patients with uncomplicated ascites based on the ANSWER trial: the Spanish healthcare system perspective. Med Clin. 2025;165(5):107154. https:\/\/doi.org\/10.1016\/j.medcli.2025.107154.","journal-title":"Med Clin"},{"issue":"3","key":"836_CR88","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304\u201377. https:\/\/doi.org\/10.1007\/s00134-017-4683-6.","journal-title":"Intensive Care Med"},{"key":"836_CR89","unstructured":"Albumin replacement therapy in septic shock (ARISS): ClinicalTrials.gov. Accessed Nov 2024. https:\/\/clinicaltrials.gov\/study\/NCT03869385"},{"issue":"1","key":"836_CR90","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1186\/s13063-020-04921-y","volume":"21","author":"Y Sakr","year":"2020","unstructured":"Sakr Y, Bauer M, Nierhaus A, Kluge S, Schumacher U, Putensen C, et al. Randomized controlled multicentre study of albumin replacement therapy in septic shock (ARISS): protocol for a randomized controlled trial. Trials. 2020;21(1):1002. https:\/\/doi.org\/10.1186\/s13063-020-04921-y.","journal-title":"Trials"},{"key":"836_CR91","unstructured":"ALBumin Italian outcome septic shock-balanced trial (ALBIOSS-BALANCED) (ALBIOSS-BAL): ClinicalTrials.gov. Accessed Nov 2024. https:\/\/clinicaltrials.gov\/study\/NCT03654001?term=NCT03654001&rank=1"},{"key":"836_CR92","unstructured":"Strong albumin solutions in patients with septic shock (SWIPE2): ClinicalTrials.gov. Accessed Mar 2025. https:\/\/clinicaltrials.gov\/study\/NCT05208242"},{"issue":"4","key":"836_CR93","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1177\/17511437241292194","volume":"25","author":"J Bannard-Smith","year":"2024","unstructured":"Bannard-Smith J, Bellomo R, Felton TW, McAuley DF, Kitchen GB, Fullwood C, et al. Small volume fluid resuscitation and supplementation with 20% albumin versus buffered crystalloids in adults with septic shock: a protocol for a randomised feasibility trial. J Intensive Care Soc. 2024;25(4):419\u201326. https:\/\/doi.org\/10.1177\/17511437241292194.","journal-title":"J Intensive Care Soc"}],"container-title":["Journal of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-025-00836-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40560-025-00836-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-025-00836-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T21:05:03Z","timestamp":1767474303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40560-025-00836-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["836"],"URL":"https:\/\/doi.org\/10.1186\/s40560-025-00836-5","relation":{},"ISSN":["2052-0492"],"issn-type":[{"value":"2052-0492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"IML, AR, LR, and SE declare that they have no competing interests. MSC has received speakers\u2019 fees from Edwards Lifesciences, Philips Healthcare and AOP Health. ACM sits on the scientific advisory board of Cambridge Infection Diagnostics and has received speaking fees from Thermo-Fisher, Biomerieux, Fischer and Paykel and Boston Scientific. ML served as a speaker for Viatris, Shionogi and Grifols and as a consultant for AOP Pharma, Biomerieux and Previa.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}